Indian Company Master Data Made Simple
Glaxosmithkline Pharmaceuticals Limited
Profile data last updated: 20/12/2024
Since its incorporation in 1924, Glaxosmithkline Pharmaceuticals Limited has accumulated more than 10 decades of experience. Its CIN is L24239MH1924PLC001151, with registration number 1151. Glaxosmithkline Pharmaceuticals Limited is identified as company limited by shares in the corporate registry. Authorized share capital stands at ₹180.00 crore. Glaxosmithkline Pharmaceuticals Limited reports paid-up capital of ₹169.41 crore.
The main line of business is manufacture of other chemical products. Registered under the jurisdiction of Mumbai. The official address of incorporation is Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030. The entity is active and conducting operations. Glaxosmithkline Pharmaceuticals Limited is registered with the PAN code AAACG4414B. The firm is registered with LEI code 3358002TNSC1U2DWNY52. Glaxosmithkline Pharmaceuticals Limited can be contacted at [email protected]. Senior management roles are held by Juby Chandy (CFO).
Company Overview
- CIN
- Date of Incorporation
- 13/11/1924
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹1,80,00,00,000.00
- Paid up Capital
- ₹1,69,40,60,340.00
- Activity
- Manufacture of other chemical products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹25,160.02L | ₹25,403.17L | ₹25,894.17L | ₹27,189.32L | ₹0.00L |
| Investment Properties | ₹78.33L | ₹91.81L | ₹106.19L | ₹120.57L | ₹0.00L |
| Accumulated Depreciation | -₹29,561.77L | -₹28,312.97L | -₹25,554.43L | -₹22,265.50L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹2,15,675.48L | ₹1,77,897.78L | ₹1,58,531.18L | ₹1,97,032.20L | ₹0.00L |
| Tangible Book Value | ₹1,93,797.90L | ₹1,75,408.59L | ₹1,70,718.22L | ₹2,62,845.84L | ₹0.00L |
| Long Term Provisions | ₹24,910.82L | ₹24,746.45L | ₹25,480.32L | ₹26,221.16L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹745.92L | ₹1,219.59L | ₹1,208.38L | ₹1,245.30L | ₹0.00L |
| Machinery Furniture Equipment | ₹44,009.06L | ₹44,885.82L | ₹42,443.79L | ₹39,369.56L | ₹0.00L |
| Total Assets | ₹4,10,806.55L | ₹3,55,661.75L | ₹3,32,658.48L | ₹4,63,327.78L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹2,66,295.58L | ₹0.00L |
| Gross PPE | ₹57,947.64L | ₹59,386.15L | ₹57,066.30L | ₹54,810.22L | ₹0.00L |
| Common Stock | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹0.00L |
| Total Capitalization | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹2,66,295.58L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹1,333.17L | ₹2,355.38L | ₹3,409.08L | ₹3,449.74L | ₹0.00L |
| Total Debt | ₹995.12L | ₹1,866.50L | ₹1,553.92L | ₹2,007.65L | ₹0.00L |
| Other Equity Interest | -₹1,487.55L | -₹900.53L | -₹167.72L | ₹2,49,355.00L | ₹0.00L |
| Capital Stock | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹16,940.60L | ₹0.00L |
| Additional Paid In Capital | ₹262.00L | ₹262.00L | ₹262.00L | ₹262.00L | ₹0.00L |
| Total Non Current Assets | ₹69,818.47L | ₹75,819.89L | ₹83,232.03L | ₹92,524.55L | ₹0.00L |
| Invested Capital | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹2,66,295.58L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹2,49,810.36L | ₹1,85,682.32L | ₹1,65,411.97L | ₹2,90,272.66L | ₹0.00L |
| Net Tangible Assets | ₹1,93,797.90L | ₹1,75,408.59L | ₹1,70,718.22L | ₹2,62,845.84L | ₹0.00L |
| Cash And Cash Equivalents | ₹53,884.77L | ₹6,417.12L | ₹3,494.09L | ₹28,618.71L | ₹0.00L |
| Prepaid Assets | ₹4,282.27L | ₹4,269.94L | ₹2,686.13L | ₹4,200.48L | ₹0.00L |
| Stockholders Equity | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹2,66,295.58L | ₹0.00L |
| Other Short Term Investments | ₹1,95,925.59L | ₹1,79,265.20L | ₹1,61,917.88L | ₹2,61,653.95L | ₹0.00L |
| Share Issued | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Current Assets | ₹3,40,988.08L | ₹2,79,841.86L | ₹2,49,426.45L | ₹3,70,803.23L | ₹0.00L |
| Working Capital | ₹1,50,472.62L | ₹1,27,347.25L | ₹1,16,789.44L | ₹2,00,960.35L | ₹0.00L |
| Ordinary Shares Number | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹249.20L | ₹646.91L | ₹345.54L | ₹762.35L | ₹0.00L |
| Current Liabilities | ₹1,90,515.46L | ₹1,52,494.61L | ₹1,32,637.01L | ₹1,69,842.88L | ₹0.00L |
| Net PPE | ₹28,385.87L | ₹31,073.18L | ₹31,511.87L | ₹32,544.72L | ₹0.00L |
| Retained Earnings | ₹1,05,863.16L | ₹87,643.52L | ₹81,149.14L | ₹1,73,149.70L | ₹0.00L |
| Construction In Progress | ₹1,431.99L | ₹1,392.96L | ₹2,031.18L | ₹3,050.21L | ₹0.00L |
| Other Non Current Assets | ₹42.80L | ₹60.60L | ₹107.74L | ₹133.18L | ₹0.00L |
| Common Stock Equity | ₹1,95,131.07L | ₹1,77,763.97L | ₹1,74,127.30L | ₹2,66,295.58L | ₹0.00L |
| Other Intangible Assets | ₹1,333.17L | ₹2,355.38L | ₹3,409.08L | ₹3,449.74L | ₹0.00L |
| Other Properties | ₹26,954.00L | ₹1,744.36L | ₹1,379.94L | ₹1,757.48L | ₹0.00L |
| Inventory | ₹48,173.68L | ₹52,504.82L | ₹45,997.04L | ₹53,469.54L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Changes In Cash | ₹47,467.65L | ₹2,923.03L | -₹25,124.62L | -₹11,900.21L |
| Financing Cash Flow | -₹76,942.02L | -₹56,149.69L | -₹1,54,332.30L | -₹52,424.23L |
| Net Income | ₹92,758.00L | ₹58,996.00L | ₹61,069.00L | ₹1,69,472.00L |
| Investing Cash Flow | -₹4,580.07L | ₹871.17L | ₹80,785.14L | -₹40,550.76L |
| Free Cash Flow | ₹1,26,517.58L | ₹55,079.40L | ₹44,018.63L | ₹77,610.68L |
| End Cash Position | ₹53,884.77L | ₹6,417.12L | ₹3,494.09L | ₹28,618.71L |
| Capital Expenditure | -₹2,472.16L | -₹3,122.15L | -₹4,403.91L | -₹3,464.10L |
| Beginning Cash Position | ₹6,417.12L | ₹3,494.09L | ₹28,618.71L | ₹40,518.92L |
| Operating Cash Flow | ₹1,28,989.74L | ₹58,201.55L | ₹48,422.54L | ₹81,074.78L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹197.68L | ₹200.52L | ₹209.79L | ₹181.29L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹92,758.29L | ₹58,996.10L | ₹60,764.22L | ₹38,076.89L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹1,32,798.46L | ₹88,766.62L | ₹90,397.94L | ₹84,923.02L | ₹0.00L |
| Operating Revenue | ₹3,72,603.47L | ₹3,44,177.08L | ₹3,22,637.87L | ₹3,26,408.12L | ₹0.00L |
| Total Expenses | ₹2,61,168.50L | ₹2,60,328.52L | ₹2,47,795.23L | ₹2,56,524.69L | ₹0.00L |
| Total Unusual Items | ₹7,282.88L | -₹9,394.98L | ₹2,983.84L | ₹1,249.26L | ₹0.00L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹1,850.58L | -₹2,604.05L | ₹815.78L | ₹374.78L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹7,282.88L | -₹9,394.98L | ₹2,983.84L | ₹1,249.26L | ₹0.00L |
| Interest Income Non Operating | ₹7,137.93L | ₹6,785.03L | ₹6,981.19L | ₹7,115.28L | ₹0.00L |
| Interest Expense Non Operating | ₹131.37L | ₹179.87L | ₹181.22L | ₹199.61L | ₹0.00L |
| Interest Income | ₹7,137.93L | ₹6,785.03L | ₹6,981.19L | ₹7,115.28L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,471.93L | ₹0.00L |
| General And Administrative Expense | ₹5,168.28L | ₹4,862.94L | ₹4,081.94L | ₹5,411.99L | ₹0.00L |
| Reconciled Depreciation | ₹6,679.25L | ₹6,967.96L | ₹6,576.72L | ₹6,818.60L | ₹0.00L |
| Net Income Continuous Operations | ₹92,758.29L | ₹58,996.10L | ₹60,764.22L | ₹38,076.89L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹1,47,303.41L | ₹1,41,984.85L | ₹1,35,872.30L | ₹1,44,965.39L | ₹0.00L |
| Operating Income | ₹1,11,434.97L | ₹83,848.56L | ₹74,842.64L | ₹69,883.43L | ₹0.00L |
| Net Income | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,471.93L | ₹0.00L |
| Diluted Average Shares | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Selling And Marketing Expense | ₹18,759.68L | ₹17,977.39L | ₹16,625.79L | ₹18,310.34L | ₹0.00L |
| Normalized Income | ₹87,325.99L | ₹65,787.03L | ₹58,596.16L | ₹37,202.41L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹7,006.56L | ₹6,605.16L | ₹6,799.97L | ₹6,915.67L | ₹0.00L |
| EBIT | ₹1,26,119.21L | ₹81,798.66L | ₹83,821.22L | ₹78,104.42L | ₹0.00L |
| Gross Profit | ₹2,25,300.06L | ₹2,02,192.23L | ₹1,86,765.57L | ₹1,81,442.73L | ₹0.00L |
| Cost Of Revenue | ₹1,47,303.41L | ₹1,41,984.85L | ₹1,35,872.30L | ₹1,44,965.39L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,471.93L | ₹0.00L |
| Net Interest Income | ₹7,006.56L | ₹6,605.16L | ₹6,799.97L | ₹6,915.67L | ₹0.00L |
| Operating Expense | ₹1,13,865.09L | ₹1,18,343.67L | ₹1,11,922.93L | ₹1,11,559.30L | ₹0.00L |
| Normalized EBITDA | ₹1,25,515.58L | ₹98,161.60L | ₹87,414.10L | ₹83,673.76L | ₹0.00L |
| Net Income Common Stockholders | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,471.93L | ₹0.00L |
| Pretax Income | ₹1,25,987.84L | ₹81,618.79L | ₹83,640.00L | ₹77,904.81L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Selling General And Administration | ₹23,927.96L | ₹22,840.33L | ₹20,707.73L | ₹23,722.33L | ₹0.00L |
| Total Revenue | ₹3,72,603.47L | ₹3,44,177.08L | ₹3,22,637.87L | ₹3,26,408.12L | ₹0.00L |
| Other Operating Expenses | ₹27,248.66L | ₹26,872.60L | ₹27,289.63L | ₹21,066.25L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹131.37L | ₹179.87L | ₹181.22L | ₹199.61L | ₹0.00L |
| Basic Average Shares | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹1,694.06L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹92,758.29L | ₹58,996.10L | ₹61,068.68L | ₹1,69,471.93L | ₹0.00L |
| Tax Provision | ₹33,229.55L | ₹22,622.69L | ₹22,875.78L | ₹39,827.92L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/11/2001 | Ajay Avinash Nadkarni | *****4414B | Company Secretary | |
| 27/07/2009 | Sundaram Damodarannair | 00016304 | Director | View other directorships |
| 28/10/2010 | Pradeep Vasudeo Bhide | 03304262 | Director | View other directorships |
| 04/11/2011 | Anami Narayan Prema Roy | 01361110 | Director | View other directorships |
| 07/04/2017 | Subesh Ronald Williams | 07786724 | Director | View other directorships |
| 01/04/2019 | Renu Sud Karnad | 00008064 | Director | View other directorships |
| 18/05/2020 | Sunita Maheshwari | 01641411 | Director | View other directorships |
| 01/04/2022 | Juby Chandy | 09530618 | Whole-time director | View other directorships |
| 01/04/2022 | Juby Chandy | *****1773F | CFO | |
| 16/05/2022 | Manu Anand | 00396716 | Director | View other directorships |
| 01/12/2022 | Bhushan Arun Akshikar | 09112346 | Managing Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 01/08/2024 | Form MGT-7-01082024_signed | - |
| 25/07/2024 | Form AOC-4(XBRL)-25072024_signed | - |
| 21/02/2024 | Form Addendum to AOC-4 CSR-21022024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030
Frequently Asked Questions
What is the incorporation date of Glaxosmithkline Pharmaceuticals Limited?
The incorporation date of Glaxosmithkline Pharmaceuticals Limited is 13/11/1924.
What is the authorized share capital and paid-up capital of Glaxosmithkline Pharmaceuticals Limited?
The authorized share capital of Glaxosmithkline Pharmaceuticals Limited is ₹1,80,00,00,000.00. The paid-up capital is ₹1,69,40,60,340.00.
Who are the current board members & directors of Glaxosmithkline Pharmaceuticals Limited?
The current board member of Glaxosmithkline Pharmaceuticals Limited are:
- Subesh Ronald Williams
- Renu Sud Karnad
- Sundaram Damodarannair
- Anami Narayan Prema Roy
- Pradeep Vasudeo Bhide
- Sunita Maheshwari
- Manu Anand
- Juby Chandy
- Bhushan Arun Akshikar
What is the registered address of Glaxosmithkline Pharmaceuticals Limited?
The registered address of Glaxosmithkline Pharmaceuticals Limited is Gsk House, Dr Annie Besant Road Worli, Mumbai City, Mumbai, Maharashtra, India, 400030.
What is the Corporate Identification Number of Glaxosmithkline Pharmaceuticals Limited?
The Corporate Identification Number of Glaxosmithkline Pharmaceuticals Limited is L24239MH1924PLC001151.